Gates Package — page 869

Let me know what you hear about results. S| 1.Z0V> >» PM d proviruses? HL8) () AID) [E] i _ = NIH/NIAID) [E] team members is coming for a visit in October so we From: "Collins, Francis (NIH/NHGRI) [E]" @nih.gov> To: "Dieffenbach, Carl (NIH/NIAID) [E]" @niaid.nih.gov> Subject: RE: Seeing Bill Gates tomorrow Date: Tue, 27 Sep 2022 18:52:58 -0400 Importance: Normal Cool! That's the kind of protocol I was hoping might work. Let me know what you hear about results. Francis From: Dieffenbach, Carl (NIH/NIAID) [E] @niaid.nih.gov> Sent: Tuesday, September 27, 2022 6:08 PM To: Collins, Francis (NIH/NHGRI) [E] @nih.gov> Cc: Gibbons, Gary (NIH/NHLBI) [E] @nih.gov>; Panepinto, Julie (NIH/NHLBI) [E] @nih.gov>; Fauci, Anthony (NIH/NIAID) [E] @niaid.nih.gov>; Tabak, Lawrence (NIH/OD) [E] @nih.gov>; Schwetz, Tara (NIH/OD) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov> Subject: Re: Seeing Bill Gates tomorrow https://medicine.temple.edu/news/first-clinical-trial-crispr-based-hiv-therapy-founded-breakthrough-research-lewis-katzschool#:~:text=The%20first%20clinical%20trial%20of,investigators%20at%20Excision%20BioTherapeutics%2C%20Inc. Francis The target is HIV. Best regards Carl On Sep 27, 2022, at 5:42 PM, Collins, Francis (NIH/NHGRI) [E] @nih.gov> wrote: Thanks, Carl. Is the anti-HIV CRISPR trial targeting CCR5 or integrated proviruses? Francis From: Dieffenbach, Carl (NIH/NIAID) [E] @niaid.nih.gov> Sent: Tuesday, September 27, 2022 9:58 AM To: Collins, Francis (NIH/NHGRI) [E] @nih.gov>; Gibbons, Gary (NIH/NHLBI) [E] @nih.gov>; Panepinto, Julie (NIH/NHLBI) [E] @nih.gov>; Fauci, Anthony (NIH/NIAID) [E] @niaid.nih.gov> Cc: Tabak, Lawrence (NIH/OD) [E] @nih.gov>; Schwetz, Tara (NIH/OD) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov> Subject: RE: Seeing Bill Gates tomorrow Francis, We have continued to meet with Mike and his team. One of his team members is coming for a visit in October so we can have a face to face deep dive.